Skip to content

Use of High Flows in Pediatric Cardiac Surgical Patients

Use of High Flow Ventilation in Pediatric Cardiac Surgical Patients

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01633801
Enrollment
80
Registered
2012-07-04
Start date
2012-08-31
Completion date
2012-12-31
Last updated
2012-08-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Congenital Heart Disease

Brief summary

Humidified high flow nasal prong oxygen therapy is a method for providing oxygen and CPAP. The delivery of high flows decreases dilution of the inhaled oxygen and, by matching patient's peak flow, allows accurate delivery of the set FiO2 throughout the whole inspiratory phase. In addition, a flow-dependent effect of continuous positive airway pressure, possibly due to an air entrainment mechanism, has been documented in healthy volunteers and in patients with COPD. The investigators working hypothesis is that the use of post-extubation CPAP delivered via nasal cannulae in infants less than 18 months, post-bypass surgery will have better PaCO2 values than infants extubated on to oxygen therapy.

Detailed description

After CICU admission, infants with no bleeding, normothermic and hemodynamically stable will be switched from PRVC to SIMV+PSV (10-15cmH20) which should be maintained for 4 hours. An arterial gas analysis will be performed after 20 minutes. Infants with normal gas-exchange are gradually weaned from mechanical ventilation At each weaning step an arterial hemogasanalysis is performed after 20 minutes, to assess if the decreased ventilatory support is tolerated. Increased work of breathing and respiratory acidosis (ph\< 7.3 or pCO2 \> 60 mmHg) are considered criteria to withhold the weaning process. After a 4 hour period on SIMV+PSV the child should be switched to PSV for 30 minutes and then extubated. The following extubation criteria should be reached: * Satisfactory blood gases with PCO2 under 45mmHg, pH greater than 7.30. * Fractional inspired oxygen concentration of 65% and or less than the baseline value * Adequate respiratory frequency according to age without dyspnea At this point criteria for extubation are reached. Once extubation has taken place the child will be placed either on traditional oxygen therapy or high flow nasal cannulae according to randomization.

Interventions

DEVICEUse of high flows versus oxygen therapy

Once extubation has taken place the child will be placed either on traditional oxygen therapy or high flow nasal cannulae according to randomization.

DEVICEoxygen therapy

Once extubation has taken place the child will be placed either on traditional oxygen therapy or high flow nasal cannulae according to randomization.

Sponsors

Bambino Gesù Hospital and Research Institute
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
1 Days to 18 Months
Healthy volunteers
No

Inclusion criteria

* Age: 0-18 months * Mechanical Ventilation via an endotracheal tube * Elective surgery * Post-bypass procedure * Rachs 2 and above

Exclusion criteria

* Presence of major congenital malformations * Presence of neuromuscular disease * Presence of non drained pneumothorax * Absent respiratory drive or recurrent apneas * Hemodynamic instability * Glasgow coma score (GCS) less than 8 * ECG with evidence of ischaemia or arrhythmias * Active bleeding

Design outcomes

Primary

MeasureTime frame
The primary aim of this study is to show an improvement of the average levels of postextubation PaCO2 in infants less than 18 months of age and post-bypass surgeryFinal outcome measure is assessed when 80 patients have been recruited.Outcome measure is assessed at the end of 48 hours postextubation and when the patient is discharged from the ICU.

Secondary

MeasureTime frameDescription
The secondary aim is to verify the reintubation rate between the two groups.Final outcome measure is assessed when 80 patients have been recruited.Outcome measure is assessed at the end of 48 hours postextubation and when the patient is discharged from the ICU.Other points that will be evaluated are: the improvement of X-ray findings, the length of ICU stay and the development of complications such as nasal ulcers and gastric distension.

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026